These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3913459)

  • 21. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.
    Douglas JM; Critchlow C; Benedetti J; Mertz GJ; Connor JD; Hintz MA; Fahnlander A; Remington M; Winter C; Corey L
    N Engl J Med; 1984 Jun; 310(24):1551-6. PubMed ID: 6328298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of recurrent herpes simplex labialis with oral acyclovir.
    Spruance SL; Stewart JC; Rowe NH; McKeough MB; Wenerstrom G; Freeman DJ
    J Infect Dis; 1990 Feb; 161(2):185-90. PubMed ID: 2153735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromes.
    Sacks SL; Fox R; Levendusky P; Stiver HG; Roland S; Nusinoff-Lehrman S; Keeney R
    Sex Transm Dis; 1988; 15(1):58-62. PubMed ID: 3282336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
    Prentice HG
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic oral acyclovir in recurrent genital herpes.
    Mindel A; Weller IV; Faherty A; Sutherland S; Hindley D; Fiddian AP; Adler MW
    Lancet; 1984 Jul; 2(8394):57-9. PubMed ID: 6146006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study.
    Saral R; Ambinder RF; Burns WH; Angelopulos CM; Griffin DE; Burke PJ; Lietman PS
    Ann Intern Med; 1983 Dec; 99(6):773-6. PubMed ID: 6359995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.
    Reichman RC; Badger GJ; Mertz GJ; Corey L; Richman DD; Connor JD; Redfield D; Savoia MC; Oxman MN; Bryson Y
    JAMA; 1984 Apr; 251(16):2103-7. PubMed ID: 6368877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients.
    Shepp DH; Dandliker PS; Flournoy N; Meyers JD
    Transplantation; 1987 May; 43(5):654-8. PubMed ID: 3554658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group.
    Reitano M; Tyring S; Lang W; Thoming C; Worm AM; Borelli S; Chambers LO; Robinson JM; Corey L
    J Infect Dis; 1998 Sep; 178(3):603-10. PubMed ID: 9728526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.
    Kinghorn GR; Woolley PD; Thin RN; De Maubeuge J; Foidart JM; Engst R
    Genitourin Med; 1992 Oct; 68(5):312-6. PubMed ID: 1385295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.
    Seale L; Jones CJ; Kathpalia S; Jackson GG; Mozes M; Maddux MS; Packham D
    JAMA; 1985 Dec; 254(24):3435-8. PubMed ID: 2999455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acyclovir and renal transplantation.
    Pettersson E; Eklund B; Höckerstedt K; Salmela K; Ahonen J
    Scand J Infect Dis Suppl; 1985; 47():145-8. PubMed ID: 3912970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of herpes simplex virus infections in susceptible patients.
    Fiddian AP
    Infection; 1987; 15 Suppl 1():S21-5. PubMed ID: 3596815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
    Wade JC; Newton B; Flournoy N; Meyers JD
    Ann Intern Med; 1984 Jun; 100(6):823-8. PubMed ID: 6326632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acyclovir in the prevention of duodenal ulcer recurrence.
    Rune SJ; Linde J; Bonnevie O; Petersen HD; Bendtsen F; Wandall JH; Gluud C; Eriksen J; Skovbjerg H; Vilien M
    Gut; 1990 Feb; 31(2):151-2. PubMed ID: 2179067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.